209 related articles for article (PubMed ID: 17178885)
1. Cationic albumin-conjugated pegylated nanoparticles allow gene delivery into brain tumors via intravenous administration.
Lu W; Sun Q; Wan J; She Z; Jiang XG
Cancer Res; 2006 Dec; 66(24):11878-87. PubMed ID: 17178885
[TBL] [Abstract][Full Text] [Related]
2. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
[TBL] [Abstract][Full Text] [Related]
3. Brain delivery property and accelerated blood clearance of cationic albumin conjugated pegylated nanoparticle.
Lu W; Wan J; She Z; Jiang X
J Control Release; 2007 Mar; 118(1):38-53. PubMed ID: 17240471
[TBL] [Abstract][Full Text] [Related]
4. Cationic albumin conjugated pegylated nanoparticle with its transcytosis ability and little toxicity against blood-brain barrier.
Lu W; Tan YZ; Hu KL; Jiang XG
Int J Pharm; 2005 May; 295(1-2):247-60. PubMed ID: 15848009
[TBL] [Abstract][Full Text] [Related]
5. Plasmid pORF-hTRAIL and doxorubicin co-delivery targeting to tumor using peptide-conjugated polyamidoamine dendrimer.
Han L; Huang R; Li J; Liu S; Huang S; Jiang C
Biomaterials; 2011 Feb; 32(4):1242-52. PubMed ID: 20971503
[TBL] [Abstract][Full Text] [Related]
6. Effective gene-virotherapy for complete eradication of tumor mediated by the combination of hTRAIL (TNFSF10) and plasminogen k5.
Liu XY; Qiu SB; Zou WG; Pei ZF; Gu JF; Luo CX; Ruan HM; Chen Y; Qi YP; Qian C
Mol Ther; 2005 Apr; 11(4):531-41. PubMed ID: 15771956
[TBL] [Abstract][Full Text] [Related]
7. Improvement of cationic albumin conjugated pegylated nanoparticles holding NC-1900, a vasopressin fragment analog, in memory deficits induced by scopolamine in mice.
Xie YL; Lu W; Jiang XG
Behav Brain Res; 2006 Oct; 173(1):76-84. PubMed ID: 16828890
[TBL] [Abstract][Full Text] [Related]
8. Aclarubicin-loaded cationic albumin-conjugated pegylated nanoparticle for glioma chemotherapy in rats.
Lu W; Wan J; Zhang Q; She Z; Jiang X
Int J Cancer; 2007 Jan; 120(2):420-31. PubMed ID: 17066446
[TBL] [Abstract][Full Text] [Related]
9. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma.
Kim SM; Lim JY; Park SI; Jeong CH; Oh JH; Jeong M; Oh W; Park SH; Sung YC; Jeun SS
Cancer Res; 2008 Dec; 68(23):9614-23. PubMed ID: 19047138
[TBL] [Abstract][Full Text] [Related]
10. Radioresponsive tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene therapy for malignant brain tumors.
Tsurushima H; Yuan X; Dillehay LE; Leong KW
Cancer Gene Ther; 2007 Aug; 14(8):706-16. PubMed ID: 17541421
[TBL] [Abstract][Full Text] [Related]
11. Brain delivery and systemic effect of cationic albumin conjugated PLGA nanoparticles.
Xu F; Lu W; Wu H; Fan L; Gao X; Jiang X
J Drug Target; 2009 Jul; 17(6):423-34. PubMed ID: 19527113
[TBL] [Abstract][Full Text] [Related]
12. The use of folate-PEG-grafted-hybranched-PEI nonviral vector for the inhibition of glioma growth in the rat.
Liang B; He ML; Chan CY; Chen YC; Li XP; Li Y; Zheng D; Lin MC; Kung HF; Shuai XT; Peng Y
Biomaterials; 2009 Aug; 30(23-24):4014-20. PubMed ID: 19427690
[TBL] [Abstract][Full Text] [Related]
13. Radiation-inducible caspase-8 gene therapy for malignant brain tumors.
Tsurushima H; Yuan X; Dillehay LE; Leong KW
Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):517-25. PubMed ID: 18407431
[TBL] [Abstract][Full Text] [Related]
14. Co-delivery of pEGFP-hTRAIL and paclitaxel to brain glioma mediated by an angiopep-conjugated liposome.
Sun X; Pang Z; Ye H; Qiu B; Guo L; Li J; Ren J; Qian Y; Zhang Q; Chen J; Jiang X
Biomaterials; 2012 Jan; 33(3):916-24. PubMed ID: 22048008
[TBL] [Abstract][Full Text] [Related]
15. Dual targeting effect of Angiopep-2-modified, DNA-loaded nanoparticles for glioma.
Huang S; Li J; Han L; Liu S; Ma H; Huang R; Jiang C
Biomaterials; 2011 Oct; 32(28):6832-8. PubMed ID: 21700333
[TBL] [Abstract][Full Text] [Related]
16. Co-delivery of TRAIL gene enhances the anti-glioblastoma effect of paclitaxel in vitro and in vivo.
Zhan C; Wei X; Qian J; Feng L; Zhu J; Lu W
J Control Release; 2012 Jun; 160(3):630-6. PubMed ID: 22410115
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas.
Corsten MF; Miranda R; Kasmieh R; Krichevsky AM; Weissleder R; Shah K
Cancer Res; 2007 Oct; 67(19):8994-9000. PubMed ID: 17908999
[TBL] [Abstract][Full Text] [Related]
18. Radio-responsive TRAIL gene therapy for malignant gliomas.
Kyritsis AP; Rao JS; Puduvalli VK
Cancer Gene Ther; 2007 Dec; 14(12):1002. PubMed ID: 17704752
[No Abstract] [Full Text] [Related]
19. Integrin-facilitated transcytosis for enhanced penetration of advanced gliomas by poly(trimethylene carbonate)-based nanoparticles encapsulating paclitaxel.
Jiang X; Sha X; Xin H; Xu X; Gu J; Xia W; Chen S; Xie Y; Chen L; Chen Y; Fang X
Biomaterials; 2013 Apr; 34(12):2969-79. PubMed ID: 23380351
[TBL] [Abstract][Full Text] [Related]
20. Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery.
Lu W; Zhang Y; Tan YZ; Hu KL; Jiang XG; Fu SK
J Control Release; 2005 Oct; 107(3):428-48. PubMed ID: 16176844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
